HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beatrice Nardone Selected Research

Immune Checkpoint Inhibitors

9/2020Bullous disorders associated with PD-1 and PD-L1 inhibitors: Pharmacovigilance analysis of the United States Food and Drug Administration Adverse Event Reporting System from the Research on Adverse Drug Events And Reports Program.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Beatrice Nardone Research Topics

Disease

7Melanoma (Melanoma, Malignant)
03/2021 - 01/2017
7Drug-Related Side Effects and Adverse Reactions
09/2020 - 05/2013
6Neoplasms (Cancer)
03/2021 - 09/2010
3Psoriasis (Pustulosis Palmaris et Plantaris)
06/2018 - 11/2009
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2018 - 01/2017
3Skin Neoplasms (Skin Cancer)
01/2018 - 01/2017
3Quadriplegia (Spastic Quadriplegia)
01/2016 - 11/2013
2Infections
01/2022 - 09/2017
2Pancreatitis
01/2018 - 05/2014
2Basal Cell Carcinoma (Rodent Ulcer)
01/2018 - 01/2017
2Spinal Cord Injuries (Spinal Cord Injury)
01/2014 - 11/2013
2Exanthema (Rash)
08/2013 - 09/2010
1Atopic Dermatitis (Atopic Eczema)
01/2022
1COVID-19
01/2022
1Acne Vulgaris
07/2019
1Hyperkalemia
07/2019
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2018
1Hypertension (High Blood Pressure)
12/2017
1Type 2 Diabetes Mellitus (MODY)
12/2017
1Sleep Initiation and Maintenance Disorders (Insomnia)
12/2017
1Osteoporosis
12/2017
1Pemphigus (Pemphigus Vulgaris)
12/2017
1Erectile Dysfunction
01/2017
1Vitiligo
12/2016
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
06/2016
1Alopecia (Baldness)
06/2015
1Fibrosis (Cirrhosis)
05/2014
1Nephrogenic Fibrosing Dermopathy
02/2014
1Anaphylaxis (Anaphylactic Shock)
01/2014
1Porcine Reproductive and Respiratory Syndrome (PRRS)
01/2014
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
08/2013
1Multiple Myeloma
08/2013
1Erythema
06/2012
1Inflammation (Inflammations)
09/2010
1Hutchinson's Melanotic Freckle (Lentigo Maligna)
11/2008
1Hyperhidrosis
07/2008
1Contact Dermatitis (Eczema, Contact)
07/2008

Drug/Important Bio-Agent (IBA)

4Pharmaceutical PreparationsIBA
01/2018 - 05/2013
4tyramine-deoxysorbitolIBA
01/2016 - 11/2013
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2019 - 10/2018
2Biological ProductsIBA
06/2018 - 09/2017
2Tumor Necrosis Factor InhibitorsIBA
06/2018 - 01/2018
2Angiotensin Receptor AntagonistsIBA
01/2018 - 01/2017
2Adrenal Cortex Hormones (Corticosteroids)IBA
12/2017 - 11/2009
2Finasteride (Propecia)FDA LinkGeneric
01/2017 - 06/2015
2Contrast MediaIBA
02/2014 - 01/2014
2GadoliniumIBA
02/2014 - 01/2014
1dupilumabIBA
01/2022
1Immune Checkpoint InhibitorsIBA
09/2020
1Spironolactone (Aldactone)FDA LinkGeneric
07/2019
1PotassiumIBA
07/2019
1Natalizumab (Tysabri)FDA Link
01/2019
1secukinumabIBA
10/2018
1Interleukin-17 (Interleukin 17)IBA
10/2018
1ixekizumabIBA
10/2018
1InterleukinsIBA
06/2018
1Interleukin-12 (IL 12)IBA
06/2018
1Cyclosporine (Ciclosporin)FDA LinkGeneric
06/2018
1Phosphodiesterase 4 InhibitorsIBA
06/2018
1Methotrexate (Mexate)FDA LinkGeneric
06/2018
1Janus Kinase 1IBA
06/2018
1blinatumomabIBA
01/2018
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2018
1Coenzyme A (CoA)IBA
01/2018
1Phosphodiesterase 5 InhibitorsIBA
01/2018
1Niacin (Nicotinic Acid)FDA LinkGeneric
01/2017
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2017
1ThiazidesIBA
01/2017
1Dutasteride (Avodart)FDA Link
01/2017
1romidepsin (FK228)FDA Link
06/2016
1Histone Deacetylase InhibitorsIBA
06/2016
1Brentuximab VedotinIBA
05/2014
1CollagenIBA
05/2014
1Dexamethasone (Maxidex)FDA LinkGeneric
08/2013
1Lenalidomide (CC 5013)FDA Link
08/2013
1Sorafenib (BAY 43-9006)FDA Link
11/2012
1Sunitinib (Sutent)FDA Link
11/2012
1salicylhydroxamic acid (SHAM)IBA
06/2012
1Erlotinib Hydrochloride (CP 358,774)FDA Link
09/2010
1Antineoplastic Agents (Antineoplastics)IBA
09/2010
1ErbB Receptors (EGF Receptor)IBA
09/2010
1Biomarkers (Surrogate Marker)IBA
09/2010
1Panitumumab (Vectibix)FDA Link
09/2010
1Lapatinib (GW572016)FDA Link
09/2010
1Cetuximab (Erbitux)FDA Link
09/2010
1Clobetasol (Clobetasol Propionate)FDA LinkGeneric
11/2009
1Imiquimod (Aldara)FDA LinkGeneric
11/2008
1aluminum sesquichlorohydrateIBA
07/2008
1Irritants (Vesicants)IBA
07/2008

Therapy/Procedure

4Therapeutics
01/2022 - 09/2010
2Body Piercing (Piercing, Body)
01/2015 - 01/2014
2Self-Help Devices (Assistive Technology)
01/2015 - 11/2013
1Immunotherapy
03/2021